(AROC) Archrock - Ratings and Ratios
Compression Services, Parts Sales, Maintenance Services, Compressor Packaging
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.11% |
| Yield on Cost 5y | 12.10% |
| Yield CAGR 5y | 3.67% |
| Payout Consistency | 96.3% |
| Payout Ratio | 51.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 33.5% |
| Value at Risk 5%th | 54.3% |
| Relative Tail Risk | -1.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.27 |
| Alpha | -12.69 |
| CAGR/Max DD | 1.60 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.361 |
| Beta | 1.264 |
| Beta Downside | 1.704 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.31% |
| Mean DD | 9.50% |
| Median DD | 9.19% |
Description: AROC Archrock November 07, 2025
Archrock, Inc. (NYSE:AROC) is a U.S.-based energy-infrastructure firm that designs, owns, installs, and operates natural-gas compression equipment, serving integrated and independent oil-and-gas processors, gatherers, and transporters.
The business is split into two operating segments: (1) Contract Operations, which generates recurring revenue by leasing its fleet of reciprocating and rotary-screw compressors on a contract basis, and (2) Aftermarket Services, which sells over-the-counter parts and provides maintenance, overhaul, and re-configuration services to third-party equipment owners.
Key economic drivers for Archrock include the U.S. natural-gas production growth (≈2 % YoY in 2023), the ongoing need for mid-stream compression capacity to maintain pipeline throughput, and capital-expenditure cycles of mid-stream operators that tend to rise when gas prices exceed $2.50 /MMBtu.
Recent performance metrics (FY 2023) show revenue of roughly $285 million, an adjusted EBITDA margin of 18 %, and a contract-backlog of $150 million, indicating a healthy pipeline of future work; the company’s fleet utilization averaged 94 % during the year, reflecting strong demand for contract compression services.
For a deeper, data-driven assessment of Archrock’s valuation and risk profile, you may find ValueRay’s analytical tools worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (265.3m TTM) > 0 and > 6% of Revenue (6% = 86.3m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -1.64pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.95% (prev 4.59%; Δ 3.36pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 532.0m > Net Income 265.3m (YES >=105%, WARN >=100%) |
| Net Debt (2.57b) to EBITDA (760.5m) ratio: 3.38 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.56 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (174.9m) change vs 12m ago 5.26% (target <= -2.0% for YES) |
| Gross Margin 64.00% (prev 58.41%; Δ 5.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 35.00% (prev 28.58%; Δ 6.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.19 (EBITDA TTM 760.5m / Interest Expense TTM 161.4m) >= 6 (WARN >= 3) |
Altman Z'' -1.54
| (A) 0.03 = (Total Current Assets 319.8m - Total Current Liabilities 205.5m) / Total Assets 4.41b |
| (B) -0.53 = Retained Earnings (Balance) -2.34b / Total Assets 4.41b |
| (C) 0.13 = EBIT TTM 514.5m / Avg Total Assets 4.11b |
| (D) -0.78 = Book Value of Equity -2.34b / Total Liabilities 2.99b |
| Total Rating: -1.54 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.67
| 1. Piotroski 5.50pt |
| 2. FCF Yield 0.27% |
| 3. FCF Margin 1.34% |
| 4. Debt/Equity 1.81 |
| 5. Debt/Ebitda 3.38 |
| 6. ROIC - WACC (= 4.44)% |
| 7. RoE 19.28% |
| 8. Rev. Trend 98.30% |
| 9. EPS Trend 86.46% |
What is the price of AROC shares?
Over the past week, the price has changed by +0.51%, over one month by +4.77%, over three months by -1.85% and over the past year by +6.68%.
Is AROC a buy, sell or hold?
- Strong Buy: 4
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AROC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.6 | 22.8% |
| Analysts Target Price | 31.6 | 22.8% |
| ValueRay Target Price | 35.5 | 38.1% |
AROC Fundamental Data Overview December 27, 2025
P/E Trailing = 17.0861
P/E Forward = 13.7931
P/S = 3.1439
P/B = 3.1812
P/EG = 1.3182
Beta = 0.938
Revenue TTM = 1.44b USD
EBIT TTM = 514.5m USD
EBITDA TTM = 760.5m USD
Long Term Debt = 2.56b USD (from longTermDebt, last quarter)
Short Term Debt = 4.12m USD (from shortTermDebt, last fiscal year)
Debt = 2.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.57b USD (from netDebt column, last quarter)
Enterprise Value = 7.09b USD (4.52b + Debt 2.57b - CCE 4.08m)
Interest Coverage Ratio = 3.19 (Ebit TTM 514.5m / Interest Expense TTM 161.4m)
FCF Yield = 0.27% (FCF TTM 19.3m / Enterprise Value 7.09b)
FCF Margin = 1.34% (FCF TTM 19.3m / Revenue TTM 1.44b)
Net Margin = 18.43% (Net Income TTM 265.3m / Revenue TTM 1.44b)
Gross Margin = 64.00% ((Revenue TTM 1.44b - Cost of Revenue TTM 518.0m) / Revenue TTM)
Gross Margin QoQ = 66.05% (prev 61.89%)
Tobins Q-Ratio = 1.61 (Enterprise Value 7.09b / Total Assets 4.41b)
Interest Expense / Debt = 1.70% (Interest Expense 43.7m / Debt 2.57b)
Taxrate = 26.25% (25.4m / 96.9m)
NOPAT = 379.4m (EBIT 514.5m * (1 - 26.25%))
Current Ratio = 1.56 (Total Current Assets 319.8m / Total Current Liabilities 205.5m)
Debt / Equity = 1.81 (Debt 2.57b / totalStockholderEquity, last quarter 1.42b)
Debt / EBITDA = 3.38 (Net Debt 2.57b / EBITDA 760.5m)
Debt / FCF = 133.0 (Net Debt 2.57b / FCF TTM 19.3m)
Total Stockholder Equity = 1.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.02% (Net Income 265.3m / Total Assets 4.41b)
RoE = 19.28% (Net Income TTM 265.3m / Total Stockholder Equity 1.38b)
RoCE = 13.07% (EBIT 514.5m / Capital Employed (Equity 1.38b + L.T.Debt 2.56b))
RoIC = 11.70% (NOPAT 379.4m / Invested Capital 3.24b)
WACC = 7.26% (E(4.52b)/V(7.10b) * Re(10.67%) + D(2.57b)/V(7.10b) * Rd(1.70%) * (1-Tc(0.26)))
Discount Rate = 10.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.51%
[DCF Debug] Terminal Value 59.61% ; FCFE base≈43.3m ; Y1≈28.4m ; Y5≈13.0m
Fair Price DCF = 1.01 (DCF Value 176.4m / Shares Outstanding 175.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 86.46 | EPS CAGR: 84.78% | SUE: -0.30 | # QB: 0
Revenue Correlation: 98.30 | Revenue CAGR: 19.63% | SUE: 0.52 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.45 | Chg30d=-0.008 | Revisions Net=-2 | Analysts=3
EPS next Year (2026-12-31): EPS=1.91 | Chg30d=-0.005 | Revisions Net=+0 | Growth EPS=+9.7% | Growth Revenue=+6.6%
Additional Sources for AROC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle